Pongamnuaykrit, M.; Tantiworawit, A.; Niprapan, P.; Punnachet, T.; Hantrakun, N.; Piriyakhuntorn, P.; Rattanathammethee, T.; Hantrakool, S.; Chai-Adisaksopha, C.; Rattarittamrong, E.;
et al. The Efficacy and Safety of Deferasirox Monotherapy as a Second-Line Treatment in Transfusion-Dependent Thalassemia with Iron Overload. J. Clin. Med. 2025, 14, 6212.
https://doi.org/10.3390/jcm14176212
AMA Style
Pongamnuaykrit M, Tantiworawit A, Niprapan P, Punnachet T, Hantrakun N, Piriyakhuntorn P, Rattanathammethee T, Hantrakool S, Chai-Adisaksopha C, Rattarittamrong E,
et al. The Efficacy and Safety of Deferasirox Monotherapy as a Second-Line Treatment in Transfusion-Dependent Thalassemia with Iron Overload. Journal of Clinical Medicine. 2025; 14(17):6212.
https://doi.org/10.3390/jcm14176212
Chicago/Turabian Style
Pongamnuaykrit, Manatchaya, Adisak Tantiworawit, Piangrawee Niprapan, Teerachat Punnachet, Nonthakorn Hantrakun, Pokpong Piriyakhuntorn, Thanawat Rattanathammethee, Sasinee Hantrakool, Chatree Chai-Adisaksopha, Ekarat Rattarittamrong,
and et al. 2025. "The Efficacy and Safety of Deferasirox Monotherapy as a Second-Line Treatment in Transfusion-Dependent Thalassemia with Iron Overload" Journal of Clinical Medicine 14, no. 17: 6212.
https://doi.org/10.3390/jcm14176212
APA Style
Pongamnuaykrit, M., Tantiworawit, A., Niprapan, P., Punnachet, T., Hantrakun, N., Piriyakhuntorn, P., Rattanathammethee, T., Hantrakool, S., Chai-Adisaksopha, C., Rattarittamrong, E., Norasetthada, L., & Charoenkwan, P.
(2025). The Efficacy and Safety of Deferasirox Monotherapy as a Second-Line Treatment in Transfusion-Dependent Thalassemia with Iron Overload. Journal of Clinical Medicine, 14(17), 6212.
https://doi.org/10.3390/jcm14176212
